193 related articles for article (PubMed ID: 6652076)
1. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ; Principe LM; Walsh WA; Friedman PA
Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
[TBL] [Abstract][Full Text] [Related]
2. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Preusch PC; Suttie JW
Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
Hazelett SE; Preusch PC
Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
[TBL] [Abstract][Full Text] [Related]
4. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
Thijssen HH; Baars LG
Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
[TBL] [Abstract][Full Text] [Related]
5. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
Mukharji I; Silverman RB
Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
[TBL] [Abstract][Full Text] [Related]
6. Indirect inhibition of vitamin K epoxide reduction by salicylate.
Hildebrandt E; Suttie JW
J Pharm Pharmacol; 1984 Sep; 36(9):586-91. PubMed ID: 6149281
[TBL] [Abstract][Full Text] [Related]
7. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
Creedon KA; Suttie JW
Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
Thijssen HH; Baars LG; Vervoort-Peters HT
Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
[TBL] [Abstract][Full Text] [Related]
10. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
Hallak HO; Wedlund PJ
Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
[No Abstract] [Full Text] [Related]
12. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase.
Preusch PC; Hazelett SE; Lemasters KK
Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837
[TBL] [Abstract][Full Text] [Related]
13. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
Fasco MJ; Principe LM
J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
[TBL] [Abstract][Full Text] [Related]
14. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
Thijssen HH
Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
Hildebrandt EF; Preusch PC; Patterson JL; Suttie JW
Arch Biochem Biophys; 1984 Feb; 228(2):480-92. PubMed ID: 6696443
[TBL] [Abstract][Full Text] [Related]
16. The effect of S-warfarin administration on vitamin K 2,3-epoxide reductase activity in liver, kidney and testis of the rat.
Thijssen HH; Janssen CA; Drittij-Reijnders MJ
Biochem Pharmacol; 1986 Oct; 35(19):3277-82. PubMed ID: 3768021
[TBL] [Abstract][Full Text] [Related]
17. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
Trivedi LS; Rhee M; Galivan JH; Fasco MJ
Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132
[TBL] [Abstract][Full Text] [Related]
18. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
Wallin R; Patrick SD; Martin LF
Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
[TBL] [Abstract][Full Text] [Related]
19. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
[TBL] [Abstract][Full Text] [Related]
20. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
MacNicoll AD
Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
